FDA 510(k)

ATLAAS (Système Appendage Atrial Gauche Atraumatique) (AD)

Numéro K : K252917 · 2026-05-22

Date de décision2026-05-22

Code produitPZX

Comité consultatifSU

DécisionSubstantially Equivalent

Résumé du dispositif

ATLAAS (Atraumatic Left Atrial Appendage System) (AD) is the device name listed in this FDA 510(k) record. The listed applicant is Genesee Biomedical, Inc.. It received FDA 510(k) clearance on 2026-05-22 under 510(k) number K252917. The device is classified under product code PZX. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Questions fréquentes

What is the ATLAAS (Atraumatic Left Atrial Appendage System) (AD)?

ATLAAS (Atraumatic Left Atrial Appendage System) (AD) is a medical device that received FDA 510(k) clearance on 2026-05-22. The listed applicant is Genesee Biomedical, Inc.. The 510(k) number is K252917.

When did ATLAAS (Atraumatic Left Atrial Appendage System) (AD) receive FDA 510(k) clearance?

ATLAAS (Atraumatic Left Atrial Appendage System) (AD) received FDA 510(k) clearance on 2026-05-22, under 510(k) number K252917.

Who is the listed applicant for ATLAAS (Atraumatic Left Atrial Appendage System) (AD)?

The FDA 510(k) record lists Genesee Biomedical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ATLAAS (Atraumatic Left Atrial Appendage System) (AD)?

The FDA product code for ATLAAS (Atraumatic Left Atrial Appendage System) (AD) is PZX.

Essais cliniques associés

Les enregistrements connexes sont mis en correspondance automatiquement à l'aide des noms, codes produits ou autres métadonnées. Une mise en correspondance n'établit pas de relation clinique, scientifique, corporative ou réglementaire vérifiée ; veuillez consulter les sources officielles liées.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Autres dossiers indiquant Genesee Biomedical, Inc. en tant que demandeur

K250859TransForm McCarthy Mitral Annuloplasty Ring (TF)K232599TransForm McCarthy Mitral Annuloplasty Ring (TF)K230679WellsForm Tricuspid Annuloplasty Band (WF)K202253TruForm Sievers Annuloplasty Ring K190506NeoForm Annuloplasty Ring K161815FlexForm Annuloplasty Ring and FlexForm Annuloplasty Band

Voir tous les 7 dispositifs →

Dispositifs connexes (Code : PZX)

K254232ECLIPTIS Left Atrial Appendage Exclusion System (ECS135); ECLIPTIS Left Atrial Appendage Exclusion System (ECS140); ECLIPTIS Left Atrial Appendage Exclusion System (ECS145); ECLIPTIS Left Atrial Appendage Exclusion System (ECS150)Edwards Lifesciences K243860AtriClip PRO-Mini LAA Exclusion System (PROM)AtriCure, Inc.K234125AtriClip FLEX-Mini LAA Exclusion System (ACHM)AtriCure, Inc.K233407AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (LAA0); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (ACH1); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (ACH2); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (PRO1); AtriClip LAA Exclusion System with preloaded Gillinov-Cosgrove Clip (PRO2); AtriClip PRO-V LAA Exclusion System (PROV); AtriClip Flex-V LAA Exclusion System with preloaded V Clip (ACHV)AtriCure, Inc.K232295LAA Exclusion SystemSyntheon, LLC K220305Syntheon LAA Exclusion System, Syntheon LAA Selection GuideSyntheon

Source officielle

Voir dans la base de données FDA →

Données issues de l'API ouverte de la FDA. Pour les informations les plus récentes et faisant autorité, veuillez toujours vous référer au registre officiel.